Hypermethylation of multiple genes in pancreatic adenocarcinoma

Cancer Research

Volumn 60, Issue 7, 2000, Pages 1835-1839

  Ueki, Takashi ^a   Toyota, Minoru ^a   Sohn, Taylor ^a   Yeo, Charles J ^a   Issa, Jean Pierre J ^a   Hruban, Ralph H ^a   Goggins, Michael ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; CALCIUM CHANNEL; DNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN P16; RETINOIC ACID RECEPTOR; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UVOMORULIN;

ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; GENE LOCUS; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROSATELLITE INSTABILITY; NUCLEOTIDE SEQUENCE; PANCREAS ADENOCARCINOMA; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; APOPTOSIS REGULATORY PROTEINS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM CHANNELS, T-TYPE; DINUCLEOSIDE PHOSPHATES; DNA METHYLATION; HUMANS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PANCREAS; PANCREATIC NEOPLASMS; PROMOTER REGIONS (GENETICS); RECEPTORS, RETINOIC ACID; THROMBOSPONDINS; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TRANSPLANTATION, HETEROLOGOUS;

EID: 0034075153     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Goelz, S. E., Vogelstein, B., Hamilton, S. R., and Feinberg, A. P. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science (Washington DC), 228: 187-190, 1985.
2. Baylin, S. B., Herman, J. G., Graff, J. R., Vertino, P. M., and Issa, J. P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res., 72: 141-196, 1998.
3. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA, 93: 9821-9826, 1996.
4. Herman, J. G., Umar, A., Polyak, K., Graff, J. R., Ahuja, N., Issa, J. P., Markowitz, S., Willson, J. K., Hamilton, S. R., Kinzler, K. W., Kane, M. F., Kolodner, R. D., Vogelstein, B., Kunkel, T. A., and Baylin, S. B. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. USA, 95: 6870-6875, 1998.
5. Schutte, M., Hruban, R. H., Geradts, J., Maynard, R., Hilgers, W., Rabindran, S. K., Moskaluk, C. A., Hahn, S. A., Schwarte-Waldhoff, I., Schmiegel, W., Baylin, S. B., Kern, S. E., and Herman, J. G. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res., 57: 3126-3130, 1997.
6. Goggins, M., Kern, S. E., Offerhaus, J. A., and Hruban, R. H. Progress in cancer genetics: lessons from pancreatic cancer. Ann. Oncol., 10: 4-8, 1999.
7. Goggins, M., Offerhaus, G. J., Hilgers, W., Griffin, C. A., Shekher, M., Tang, D., Sohn, T. A., Yeo, C. J., Kern, S. E., and Hruban, R. H. Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+. Am. J. Pathol., 152: 1501-1507, 1998.
8. Belinsky, S. A., Nikula, K. J., Palmisano, W. A., Michels, R., Saccomanno, G., Gabrielson, E., Baylin, S. B., and Herman, J. G. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc. Natl. Acad. Sci. USA, 95: 11891-11896, 1998.
9. Bachman, K. E., Herman, J. G., Corn, P. G., Merlo, A., Costello, J. F., Cavenee, W. K., Baylin, S. B., and Graff, J. R. Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers. Cancer Res., 59: 798-802, 1999.
10. Esteller, M., Sanchez-Cespedes, M., Rosell, R., Sidransky, D., Baylin, S. B., and Herman, J. G. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res., 59: 67-70, 1999.
11. Cote, S., Sinnett, D., and Momparler, R. L. Demethylation by 5-aza-2′-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells. Anticancer Drugs, 9: 743-750, 1998.
12. Li, Q., Ahuja, N., Burger, P. C., and Issa, J. P. Methylation and silencing of the thrombospondin-1 promoter in human cancer. Oncogene, 18: 3284-3289, 1999.
13. Toyota, M., Ho, C., Ohe-Toyota, M., Baylin, S. B., and Issa, J. P. Inactivation of CACNAIG, a T-type calcium channel gene, by aberrant methylation of its 5′ CpG island in human tumors. Cancer Res., 59: 4535-4541, 1999.
14. Deng, G., Chen, A., Hong, J., Chae, H. S., and Kim, Y. S. Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res., 59: 2029-2033, 1999.
15. Toyota, M., Ho, C., Ahuja, N., Jair, K. W., Li, Q., Ohe-Toyota, M., Baylin, S. B., and Issa, J. P. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res., 59: 2307-2312, 1999.
16. Rozenblum, E., Schutte, M., Goggins, M., Hahn, S. A., Panzer, S., Zahurak, M., Goodman, S. N., Sohn, T. A., Hruban, R. H., Yeo, C. J., and Kern, S. E. Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res., 57: 1731-1734, 1997.
17. Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., and Issa, J. P. CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. USA, 96: 8681-8686, 1999.
18. Toyota, M., Ahuja, N., Suzuki, H., Itoh, F., Ohe-Toyota, M., Imai, K., Baylin, S. B., and Issa, J. P. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res., 59: 5438-5442, 1999.
19. Liang, G., Salem, C. E., Yu, M. C., Nguyen, H. D., Gonzales, F. A., Nguyen, T. T., Nichols, P. W., and Jones, P. A. DNA methylation differences associated with tumor tissues identified by genome scanning analysis. Genomics, 53: 260-268, 1998.
20. Melki, J. R., Vincent, P. C., and Clark, S. J. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res., 59: 3730-3740, 1999.
21. Wiencke, J. K., Zheng, S., Lafuente, A., Lafuente, M. J., Grudzen, C., Wrensch, M. R., Miike, R., Ballesta, A., and Trias, M. Aberrant methylation of p16INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer. Cancer Epidemiol. Biomark. Prev., 8: 501-506, 1999.
22. Toyota, M., Ohe-Toyota, M., Ahuja, N., and Issa, J. P. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc. Natl. Acad. Sci. USA, 97: 710-715, 2000.
23. Hirotsune, S., Hatada, I., Komatsubara, H., Nagai, H., Kuma, K., Kobayakawa, K., Kawara, T., Nakagawara, A., Fujii, K., Mukai, T., and Hayashizaki, Y. New approach for detection of amplification in cancer DNA using restriction landmark genomic scanning. Cancer Res., 52: 3642-3647, 1992.
24. Issa, J. P., Baylin, S. B., and Belinsky, S. A. Methylation of the estrogen receptor CpG island in lung tumors is related to the specific type of carcinogen exposure. Cancer Res., 56: 3655-3658, 1996.
25. Antequera, F., Boyes, J., and Bird, A. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell, 62: 503-514, 1990.